celecoxib and prostaglandin d2

celecoxib has been researched along with prostaglandin d2 in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajuebor, MN; Singh, A; Wallace, JL1
Levine, L1
Bourdi, M; Brady, JN; George, JW; Marchick, MR; Pise-Masison, CA; Pohl, LR; Radonovich, MF; Reilly, TP1
Badawi, AF; Badr, MZ; Eldeen, MB; Liu, Y; Ross, EA1
Arroyo, V; Clària, J; Jiménez, W; López-Parra, M; Masferrer, JL; Párrizas, M; Planagumà, A; Rivera, F; Rodés, J; Titos, E1
Bjorling, DE; Calamon-Dixon, JL; Jerde, TJ; Nakada, SY1
Gitlin, JM; King, VL; Loftin, CD; Trivedi, DB1
Amin, AR; Dave, M1
Meschede, AK; Schebb, NH; Willenberg, I1
Ding, WY; Guan, PP; Guo, JW; Huang, XS; Wang, P; Wang, SL; Wang, ZY1

Other Studies

10 other study(ies) available for celecoxib and prostaglandin d2

ArticleYear
Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.
    American journal of physiology. Gastrointestinal and liver physiology, 2000, Volume: 279, Issue:1

    Topics: Animals; Blotting, Western; Celecoxib; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hydantoins; Indomethacin; Intramolecular Oxidoreductases; Isoenzymes; Lipocalins; Male; Necrosis; Neutrophils; Peroxidase; Peroxisomes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger; Sulfonamides; Transcription Factors

2000
Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors.
    Prostaglandins, leukotrienes, and essential fatty acids, 2001, Volume: 65, Issue:4

    Topics: Alitretinoin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cell Line; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Indomethacin; Kinetics; Liver; Prostaglandin D2; Prostaglandins A; Pyrazoles; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin

2001
A protective role for cyclooxygenase-2 in drug-induced liver injury in mice.
    Chemical research in toxicology, 2001, Volume: 14, Issue:12

    Topics: Acetaminophen; Animals; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; DNA Primers; Gene Expression Profiling; Immunoblotting; Isoenzymes; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Survival Rate

2001
Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Cancer research, 2004, Feb-01, Volume: 64, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Carcinogens; Celecoxib; Cell Cycle; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Female; Fluorenes; Isoenzymes; Leucine; Mammary Neoplasms, Experimental; Methylnitrosourea; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Transcription Factors

2004
The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin.
    Journal of hepatology, 2005, Volume: 42, Issue:1

    Topics: Actins; Albumins; Animals; Arachidonic Acid; Celecoxib; Cyclooxygenase Inhibitors; Eicosanoids; Male; PPAR gamma; Prostaglandin D2; Pyrazoles; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides

2005
Celecoxib inhibits ureteral contractility and prostanoid release.
    Urology, 2005, Volume: 65, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase Inhibitors; Depression, Chemical; Dimethyl Sulfoxide; Dinoprost; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Indomethacin; Muscle Contraction; Nitrobenzenes; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Pyrazoles; Secretory Rate; Sulfonamides; Sus scrofa; Thromboxane A2; Tumor Necrosis Factor-alpha; Ureter; Ureteral Obstruction

2005
Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:5

    Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Hypercholesterolemia; Male; Mice; Mice, Inbred C57BL; Prostaglandin D2; Pyrazoles; Sulfonamides

2006
Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib.
    Immunology letters, 2013, Volume: 152, Issue:1

    Topics: Celecoxib; Cells, Cultured; Chondrocytes; Dinoprost; Dinoprostone; Humans; Inflammation Mediators; Interleukin-1beta; Knee; Leukotriene B4; Nitric Oxide; Osteoarthritis; Prostaglandin D2; Prostaglandins F; Pyrazoles; Sulfonamides; Thromboxane B2

2013
Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2).
    Journal of chromatography. A, 2015, Apr-24, Volume: 1391

    Topics: Celecoxib; Cell Line; Chromatography, Liquid; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dexamethasone; Dinoprostone; Humans; Indomethacin; Lipopolysaccharides; Monocytes; Prostaglandin D2; Pyrazoles; Recombinant Proteins; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Sulfonamides; Tandem Mass Spectrometry; Thromboxane B2

2015
Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP/PS1 transgenic mice.
    Biomaterials, 2017, Volume: 145

    Topics: 14-3-3 Proteins; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Apoptosis Regulatory Proteins; beta-Arrestin 1; Brain; Celecoxib; Cell Line, Tumor; Cell Movement; Cognitive Dysfunction; Dinoprostone; Erythrocyte Membrane; HEK293 Cells; Humans; Liposomes; Mice, Transgenic; Mitochondrial Proteins; Models, Biological; Neural Stem Cells; Neurogenesis; Neurons; Phospholipids; Presenilin-1; Prostaglandin D2; Rats, Wistar; Superoxide Dismutase; Tissue Distribution; Up-Regulation

2017